Trial Profile
A parallel, double-blinded, randomized, 6 months, two arms study with lifestyle intervention and exenatide 2 mg once weekly or lifestyle intervention and placebo in adolescents with obesity to explore differences between groups with regard to change in BMI SDS (according to WHO).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 May 2022
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms Combat-JUDO
- 17 May 2022 Status changed from active, no longer recruiting to completed.
- 14 Jan 2017 This trial has been completed in Sweden (End date:2016-09-13) as per European Clinical Trials Database record.
- 08 Jun 2016 Status changed from recruiting to active, no longer recruiting.